B cells: new ways to inhibit their function in rheumatoid arthritis

Current Rheumatology Reports
Robert H Carter

Abstract

The apparent efficacy of B-cell depletion in autoimmune diseases has increased interest in targeting B cells. One goal of next generation therapies is to develop treatments that block B-cell activation and preserve resting nonautoimmune cells that maintain B cell memory. To do so, one needs to understand how B cells are activated and what receptors and intracellular signaling pathways regulate this process. This paper will summarize B-cell activation pathways and illustrate how these are being targeted in the development of new treatments for rheumatoid arthritis.

References

Jul 1, 1995·Immunology Today·G Kelsoe
Jul 1, 1994·The Journal of Experimental Medicine·G Kelsoe
Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·A E SchröderC Berek
Jan 1, 1996·Annual Review of Immunology·T M FoyR J Noelle
Jun 1, 1996·Current Opinion in Immunology·G M DoodyD T Fearon
May 23, 1998·Annual Review of Immunology·W J Leonard, J J O'Shea
Oct 23, 1998·The Journal of Experimental Medicine·M C CookA Basten
Nov 18, 1998·Immunology Today·S A CamachoC Berek
Aug 3, 1999·The Journal of Experimental Medicine·Y TakahashiG Kelsoe
Oct 26, 1999·Current Topics in Microbiology and Immunology·D M CalderheadR J Noelle
Feb 12, 2000·European Journal of Immunology·I VoigtC Berek
Jun 3, 2000·Annual Review of Immunology·D T Fearon, M C Carroll
Jun 3, 2000·Annual Review of Immunology·M Karin, Y Ben-Neriah
Jul 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·I R RifkinA Marshak-Rothstein
Oct 29, 2000·Annals of the Rheumatic Diseases·J J O'SheaM Gadina
Nov 30, 2000·The Journal of Biological Chemistry·G R Crabtree
Dec 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J ZhangT Zhou
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·H BrühlM Mack
Mar 10, 2001·Nature·L Chang, M Karin
Jul 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S TakemuraC M Weyand
Oct 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S TakemuraC M Weyand
Mar 5, 2002·Nature Immunology·Michael Karin, Anning Lin
Mar 22, 2002·Nature Reviews. Immunology·John J O'SheaPeter Lipsky
Apr 12, 2002·Nature·Elizabeth A LeadbetterAnn Marshak-Rothstein
Apr 26, 2002·Current Opinion in Immunology·Tomohiro Kurosaki
May 2, 2002·Cell·Gerald R Crabtree, Eric N Olson
May 2, 2002·Cell·John J O'SheaRobert D Schreiber
Jun 1, 2002·Science·Stephen B GauldJohn C Cambier
Jul 3, 2002·Nature Reviews. Immunology·Fabienne Mackay, Jeffrey L Browning
Jul 20, 2002·Science·Theresa T Lu, Jason G Cyster
Aug 3, 2002·Nature Immunology·Mikhail B LitinskiyAndrea Cerutti
Aug 16, 2002·Transplant Immunology·Russell L DedrickMarvin Garovoy
Sep 14, 2002·Annals of the Rheumatic Diseases·M J LeandroG Cambridge
Sep 28, 2002·Nature Immunology·Estefania ClaudioUlrich Siebenlist

❮ Previous
Next ❯

Citations

Mar 15, 2006·Mayo Clinic Proceedings·Robert H Carter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.